prescription drugs
publication date
Strategy
Pharmacies Face Extra Audit Burdens That Threaten Their ExistencePharmacy benefit managers, or PBMs, suspended in-person audits because of covid last year, shifting to virtual audits, much as in-person...
Payer
Diabetes Drug's New Weight Loss Formula Fuels Cost-Benefit DebateIt's no surprise that some of the same drugs for diabetes are being reformulated and renamed by manufacturers as a...
Payer
Pfizer Court Fight Could Legalize Medicare Copays and Unleash 'Gold Rush' in SalesA Pfizer win could cost taxpayers billions of dollars and erase an important control on pharma marketing after decades of...
Innovation
Analytics and Hospital Pharmacies: Building a Successful ProgramThe requests received for data became more complex, requiring some to move away from just patient use data and incorporate...
Strategy
Biden's July Executive Order Includes Drug Pricing Provisions. But Will They Do Enough?So far, experts generally say the jury is still out on how meaningful these efforts will be.
Clinical Care
Medication Non-Adherence: Solving an Eternal ChallengeHealthcare plans for the underserved markets, which include patients using Medicaid, Medicare Dual Advantage, or a healthcare exchange, offer limited...
Strategy
AHA, 340B Health Applaud SCOTUS Decision to Hear Medicare Cuts CaseThe AHA applauded the Supreme Court's announcement in a statement released Friday morning.
Clinical Care
How One Rural Town Without a Pharmacy Is Crowdsourcing to Get MedsWalden, Colorado has suffered the fate of many small towns across the United States, as the economics of the pharmacy...
Strategy
States Step Up Push to Regulate Pharmacy Drug BrokersThe companies are powerful, together administering medication plans for more than 266 million Americans.
Payer
Change to Gilead Assistance Program Threatens PrEP Access, HIV Advocates SayThe Advancing Access program offers free medicine to the uninsured.
Innovation
FDA Weighs Approval of a Lucrative Alzheimer's Drug, but Benefits Are IffyThe agency said it will decide by June 7 the fate of Biogen's drug aducanumab.
Strategy
Podcast: KHN's 'What the Health?': Drug Price Effort Hits a SnagConcerns raised by a group of moderate Democrats threaten to derail a bill being pushed by House Democratic leaders.